CA1247538A
(en)
*
|
1982-05-21 |
1988-12-28 |
Mark C. Glassy |
Human-human hybridomas for solid tumors
|
US4613576A
(en)
*
|
1983-03-09 |
1986-09-23 |
Sloan-Kettering Institute For Cancer Research |
Human monoclonal antibodies to cancer cells
|
US4634666A
(en)
*
|
1984-01-06 |
1987-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human-murine hybridoma fusion partner
|
EP0148644A3
(en)
*
|
1984-01-06 |
1987-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
A novel fusion partner and its products
|
US4764465A
(en)
*
|
1984-04-26 |
1988-08-16 |
Cetus Corporation |
Human monoclonal antibody against group A red blood cells
|
DE3581400D1
(de)
*
|
1984-09-28 |
1991-02-21 |
Teijin Ltd |
Maus/mensch-hybridoma mit erzeugung von antiviralen menschlichen antikoerpern, deren herstellung und antivirale menschliche monoklonale antikoerper.
|
JPS6187630A
(ja)
*
|
1984-10-08 |
1986-05-06 |
Teijin Ltd |
単純ヘルペスウイルスに対するヒトモノクロ−ナル抗体及びその製造法
|
US4693975A
(en)
*
|
1984-11-20 |
1987-09-15 |
The Wistar Institute |
Human hybridroma fusion partner for production of human monoclonal antibodies
|
JPS61155398A
(ja)
*
|
1984-12-28 |
1986-07-15 |
Teijin Ltd |
抗緑膿菌ヒトモノクロ−ナル抗体及びその製造法並びにそれを有効成分とする治療剤
|
US4677070A
(en)
*
|
1985-04-26 |
1987-06-30 |
Cetus Corporation |
Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
|
USH1198H
(en)
|
1985-04-26 |
1993-06-01 |
Cetus Corporation |
Pseudomonas aeruginosa type-specific human monoclonal antibodies, their preparation and use
|
CH670098B
(ja)
*
|
1985-05-23 |
1989-05-12 |
|
|
JPH0720885B2
(ja)
*
|
1985-09-27 |
1995-03-08 |
帝人株式会社 |
単純ヘルペスウイルス感染症の予防又は治療剤
|
NZ218499A
(en)
*
|
1985-12-10 |
1990-04-26 |
Genetic Systems Corp |
Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
|
AU613310B2
(en)
*
|
1986-04-01 |
1991-08-01 |
Genelabs Incorporated |
Immortalized virus-specific tissue cells
|
EP0262211A1
(en)
*
|
1986-04-01 |
1988-04-06 |
Genelabs, Incorporated |
Immortalized cells which produce tissue-specific products
|
US5565354A
(en)
*
|
1986-09-05 |
1996-10-15 |
Sandoz Ltd. |
Production of human monoclonal antibodies specific for hepatitis B surface antigen
|
US5646041A
(en)
*
|
1987-02-12 |
1997-07-08 |
Harfeldt; Elisabeth |
Monoclonal antibody to herpes simplex virus and cell line producing same
|
US5001065A
(en)
*
|
1987-05-27 |
1991-03-19 |
Cetus Corporation |
Human cell line and triomas, antibodies, and transformants derived therefrom
|
JPH01101896A
(ja)
*
|
1987-10-14 |
1989-04-19 |
Teijin Ltd |
カンジダに対するヒト・モノクローナル抗体とその製造法
|
US5215913A
(en)
|
1987-11-30 |
1993-06-01 |
Roger Williams General Hospital |
IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
|
IT1226477B
(it)
*
|
1988-07-04 |
1991-01-16 |
Genetik Mab S R L |
Linee cellulari n omas quale un mezzo per immortalare cellule produttrici di sostanze di qualunque specie animale.
|
US7041871B1
(en)
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5770429A
(en)
*
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
JP2535455B2
(ja)
*
|
1991-02-07 |
1996-09-18 |
帝人株式会社 |
サイトメガロウイルスに対するヒト・モノクロ―ナル抗体を産生するハイブリド―マ
|
ES2199216T3
(es)
*
|
1991-07-15 |
2004-02-16 |
The Wellcome Foundation Limited |
Produccion de anticuerpos.
|
JPH05276984A
(ja)
*
|
1991-09-05 |
1993-10-26 |
Teijin Ltd |
カンジダに対するヒト・モノクローナル抗体を産生するハイブリドーマ
|
JPH05260961A
(ja)
*
|
1992-05-21 |
1993-10-12 |
Teijin Ltd |
サイトメガロウイルスに対するヒト・モノクローナル抗体を産生するハイブリドーマ
|
BR9305557A
(pt)
*
|
1992-06-26 |
1997-03-25 |
Aetsrn |
Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém
|
EP0583980A1
(en)
*
|
1992-08-20 |
1994-02-23 |
Eli Lilly And Company |
Method for generating monoclonal antibodies from rabbits
|
CZ116495A3
(en)
*
|
1992-11-06 |
1996-05-15 |
Sandoz Ltd |
Production of human monoclonal antibodies against hepatitis b surface antigen
|
US5750106A
(en)
*
|
1993-01-28 |
1998-05-12 |
Novartis Ag |
Human monoclonal antibodies to cytomegalovirus
|
AU2527397A
(en)
*
|
1996-03-13 |
1997-10-01 |
Protein Design Labs, Inc. |
Fas ligand fusion proteins and their uses
|
ES2331595T3
(es)
|
1997-02-07 |
2010-01-08 |
The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services |
Factor neurotrofico dependiente de actividad iii (adnf iii).
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US6197582B1
(en)
|
1998-03-18 |
2001-03-06 |
The Trustees Of Columbia University In The City Of New York |
Development of human monoclonal antibodies and uses thereof
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
AU1456101A
(en)
*
|
1999-11-03 |
2001-05-14 |
Maxygen, Inc. |
Antibody diversity generation
|
US7060802B1
(en)
*
|
2000-09-18 |
2006-06-13 |
The Trustees Of Columbia University In The City Of New York |
Tumor-associated marker
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
ES2464532T3
(es)
|
2001-04-19 |
2014-06-03 |
The Scripps Research Institute |
Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
|
US7084257B2
(en)
*
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
WO2003047623A1
(en)
*
|
2001-10-11 |
2003-06-12 |
Protein Design Labs Inc. |
Treatment of prostate cancer by inhibitors of ncam2
|
ATE541047T1
(de)
|
2002-08-01 |
2012-01-15 |
Univ California |
Therapeutische monoklonale antikörper zur neutralisierung von botulinum neurotoxinen
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
HUE034320T2
(en)
|
2003-05-19 |
2018-02-28 |
Prothena Biosciences Ltd |
Truncated fragments of alpha-synuclein in lewy-body disease
|
US7358331B2
(en)
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
US7566458B2
(en)
|
2003-06-16 |
2009-07-28 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
BRPI0411475A
(pt)
|
2003-06-18 |
2006-07-25 |
Scripps Research Inst |
adições de código genético de aminoácido reativo não natural
|
ES2533382T3
(es)
|
2004-05-25 |
2015-04-09 |
Medimmune, Llc |
Variantes de la hemaglutinina y la neuraminidasa de influenza
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
EA013752B1
(ru)
|
2004-08-09 |
2010-06-30 |
Элан Фармасьютикалз, Инк. |
Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
EP1855715B1
(en)
|
2005-01-27 |
2013-03-13 |
Children's Hospital & Research Center at Oakland |
Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
|
CN101146554B
(zh)
|
2005-01-27 |
2012-10-10 |
加州大学评议会 |
中和肉毒杆菌神经毒素的治疗性单克隆抗体
|
EP2441471B1
(en)
|
2005-03-08 |
2014-10-08 |
MedImmune, LLC |
Reassortant influenza viruses
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
ES2346691T3
(es)
*
|
2005-08-02 |
2010-10-19 |
Xbiotech, Inc |
Diagnostico, tratamiento y prevencion de trastornos vasculares usando autoanticuerpos il-1alfa.
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
EP1934867A2
(en)
*
|
2005-08-31 |
2008-06-25 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
DOP2006000277A
(es)
|
2005-12-12 |
2007-08-31 |
Bayer Pharmaceuticals Corp |
Anticuerpos anti mn y métodos para su utilización
|
WO2007117410A2
(en)
|
2006-03-31 |
2007-10-18 |
Medarex, Inc. |
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
|
RU2431667C9
(ru)
|
2006-04-13 |
2012-03-27 |
Медикал Энд Байолоджикал Лэборетериз Ко., Лтд. |
Слитые клетки-партнеры
|
WO2007127335A2
(en)
*
|
2006-04-27 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways
|
US20110008282A1
(en)
*
|
2006-05-15 |
2011-01-13 |
Xbiotech, Inc. |
IL-1alpha immunization induces autoantibodies protective against atherosclerosis
|
ES2374845T3
(es)
*
|
2006-05-22 |
2012-02-22 |
Xbiotech, Inc |
Tratamiento de cáncer con anticuerpos anti-il-1.
|
US9683026B2
(en)
|
2006-07-19 |
2017-06-20 |
The Trustees Of The University Of Pennslyvania |
WSX-1/P28 as a target for anti-inflammatory responses
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
WO2008083169A2
(en)
*
|
2006-12-26 |
2008-07-10 |
The Johns Hopkins University |
Compositions and methods for the treatment of immunologic disorders
|
JP5481199B2
(ja)
*
|
2006-12-27 |
2014-04-23 |
ザ ジョンズ ホプキンス ユニバーシティー |
炎症および自己免疫疾患を治療するための組成物および方法
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
US20090142342A1
(en)
*
|
2006-12-27 |
2009-06-04 |
Johns Hopkins University |
B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases
|
HUE043966T2
(hu)
|
2007-02-23 |
2019-09-30 |
Prothena Biosciences Ltd |
Szinukleinopátiás és amiloidogén betegség megelõzése és kezelése
|
DK3067066T3
(da)
|
2007-02-23 |
2019-05-20 |
Prothena Biosciences Ltd |
Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
|
EP1972639A3
(en)
|
2007-03-07 |
2008-12-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
EP1975184A3
(en)
|
2007-03-26 |
2008-11-26 |
Cell Signaling Technology, Inc. |
Serine or threonine phosphorylation sites
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
EP2145902A3
(en)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
JP5797403B2
(ja)
|
2007-08-03 |
2015-10-21 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
ヒトモノクローナル抗体およびそれを産生する方法
|
US9624309B2
(en)
|
2007-08-15 |
2017-04-18 |
Bayer Intellectual Property Gmbh |
Monospecific and multispecific antibodies and method of use
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
CA2697373C
(en)
|
2007-08-27 |
2019-05-21 |
Longhorn Vaccines & Diagnostics, Llc |
Immunogenic compositions and methods
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
ES2552858T3
(es)
|
2007-10-01 |
2015-12-02 |
Longhorn Vaccines And Diagnostics, Llc |
Recogida de muestras biológicas y sistema de transporte y métodos de uso
|
JP2010540953A
(ja)
|
2007-10-05 |
2010-12-24 |
ナショナル インスティテュート フォー バイオプロセッシング リサーチ アンド トレーニング リミテッド |
膵炎、敗血症および膵臓癌のためのグリコシル化マーカー
|
EP2062920A3
(en)
|
2007-11-21 |
2009-06-17 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signalling pathways
|
US20090169549A1
(en)
*
|
2007-12-19 |
2009-07-02 |
The Board Of Regents Of The University Of Texas System |
Conformational isomers of alpha-synuclein, antibodies thereto and methods of their manufacture and use
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
CA2718975A1
(en)
|
2008-04-10 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting egfr mutations in cancer
|
ES2576681T3
(es)
|
2008-05-30 |
2016-07-08 |
Xbiotech, Inc |
Anticuerpos IL-1 alfa
|
EP2309264A4
(en)
*
|
2008-06-06 |
2011-11-23 |
Univ Toyama Nat Univ Corp |
FLU VIRUS DETECTION DEVICE
|
JP2011527581A
(ja)
|
2008-07-11 |
2011-11-04 |
メディミューン,エルエルシー |
インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体
|
US8242074B2
(en)
*
|
2008-09-12 |
2012-08-14 |
Xbiotech, Inc. |
Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
|
WO2010085590A1
(en)
|
2009-01-23 |
2010-07-29 |
Biosynexus Incorporated |
Opsonic and protective antibodies specific for lipoteichoic acid gram positive bacteria
|
JP5818693B2
(ja)
|
2009-02-12 |
2015-11-18 |
メディミューン,エルエルシー |
インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体
|
EP2427479B1
(en)
|
2009-05-07 |
2018-11-21 |
The Regents of The University of California |
Antibodies and methods of use thereof
|
JP2013503205A
(ja)
|
2009-08-31 |
2013-01-31 |
アンプリミューン, インコーポレイテッド |
移植拒絶反応を阻害するための方法および組成物
|
US8765432B2
(en)
|
2009-12-18 |
2014-07-01 |
Oligasis, Llc |
Targeted drug phosphorylcholine polymer conjugates
|
JP6324720B2
(ja)
|
2010-06-18 |
2018-05-16 |
エックスバイオテク, インコーポレイテッドXbiotech, Inc. |
関節炎治療
|
EP3443985B1
(en)
|
2010-08-23 |
2020-12-16 |
XBiotech, Inc |
Treatment for neoplastic diseases
|
NZ611468A
(en)
|
2010-12-06 |
2015-06-26 |
Seattle Genetics Inc |
Humanized antibodies to liv-1 and use of same to treat cancer
|
EP2694107B1
(en)
|
2011-04-01 |
2018-08-22 |
XBiotech, Inc |
Treatment for dermatological pathologies
|
US9724409B2
(en)
|
2011-04-01 |
2017-08-08 |
Xbiotech, Inc. |
Treatment of inflammatory skin disease
|
WO2013043973A2
(en)
|
2011-09-23 |
2013-03-28 |
Xbiotech, Inc. |
Cachexia treatment
|
CA2863083C
(en)
|
2012-01-26 |
2023-09-19 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
UA105278C2
(ru)
|
2012-09-06 |
2014-04-25 |
Інститут Біології Клітини Нан України |
Способ получения каталитически активных антител (абзимов) с сиалидазной активностью
|
US9545441B2
(en)
|
2012-09-18 |
2017-01-17 |
Xbiotech, Inc. |
Treatment of diabetes
|
KR102296017B1
(ko)
|
2012-10-04 |
2021-09-01 |
얀센 바이오테크 인코포레이티드 |
혈관 질환 및 이에 따른 합병증 치료
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
CN105121465B
(zh)
|
2013-03-13 |
2020-09-08 |
普罗塞纳生物科技公司 |
Tau免疫疗法
|
EP3016683B1
(en)
|
2013-07-05 |
2020-06-24 |
University of Washington through its Center for Commercialization |
Soluble mic neutralizing monoclonal antibody for treating cancer
|
US9850302B2
(en)
|
2013-07-12 |
2017-12-26 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
US9951131B2
(en)
|
2013-07-12 |
2018-04-24 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
ES2819217T3
(es)
|
2013-09-08 |
2021-04-15 |
Kodiak Sciences Inc |
Conjugados de polímeros iónicos dipolares y factor VIII
|
TW201623331A
(zh)
|
2014-03-12 |
2016-07-01 |
普羅帝納生物科學公司 |
抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
|
EP3116907A1
(en)
|
2014-03-12 |
2017-01-18 |
Prothena Biosciences Limited |
Anti-laminin4 antibodies specific for lg4-5
|
DK3116911T3
(da)
|
2014-03-12 |
2019-09-30 |
Prothena Biosciences Ltd |
Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
|
WO2015136471A1
(en)
|
2014-03-12 |
2015-09-17 |
Prothena Biosciences Limited |
Anti-laminin4 antibodies specific for lg1-3
|
US10562973B2
(en)
|
2014-04-08 |
2020-02-18 |
Prothena Bioscience Limited |
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
US20160075772A1
(en)
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
EP3207128B1
(en)
|
2014-10-17 |
2022-07-27 |
Kodiak Sciences Inc. |
Butyrylcholinesterase zwitterionic polymer conjugates
|
TWI711631B
(zh)
|
2015-01-28 |
2020-12-01 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI718121B
(zh)
|
2015-01-28 |
2021-02-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI718122B
(zh)
|
2015-01-28 |
2021-02-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
KR20170140318A
(ko)
|
2015-04-29 |
2017-12-20 |
리제너론 파마슈티칼스 인코포레이티드 |
진행성 골화성 섬유이형성증의 치료
|
CA2985652C
(en)
|
2015-05-14 |
2020-03-10 |
Gerald W. FISHER |
Rapid methods for the extraction of nucleic acids from biological samples
|
JP2018530540A
(ja)
|
2015-09-16 |
2018-10-18 |
プロセナ バイオサイエンシーズ リミテッド |
巨細胞動脈炎、リウマチ性多発筋痛症又は高安動脈炎の処置又は予防のための抗mcam抗体の使用
|
WO2017046774A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
RU2744860C2
(ru)
|
2015-12-30 |
2021-03-16 |
Кодиак Сайенсиз Инк. |
Антитела и их конъюгаты
|
WO2017149513A1
(en)
|
2016-03-03 |
2017-09-08 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
CA3014934A1
(en)
|
2016-03-04 |
2017-09-08 |
JN Biosciences, LLC |
Antibodies to tigit
|
WO2017153953A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
WO2017153955A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
BR112018072394A2
(pt)
|
2016-05-02 |
2019-02-19 |
Prothena Biosciences Limited |
anticorpos que reconhecem a tau
|
KR102471787B1
(ko)
|
2016-05-02 |
2022-11-29 |
프로테나 바이오사이언시즈 리미티드 |
타우 인식 항체
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
WO2018007923A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
WO2018007922A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
WO2018007924A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
JP2019522800A
(ja)
|
2016-07-06 |
2019-08-15 |
プロセナ バイオサイエンシーズ リミテッド |
総及びS129リン酸化α−シヌクレインの検出アッセイ
|
CA3053231A1
(en)
|
2017-02-16 |
2018-08-23 |
Xbiotech Inc. |
Treatment of hidradenitis suppurativa
|
CA3059938A1
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
CN110881274A
(zh)
|
2017-05-02 |
2020-03-13 |
普罗塞纳生物科学有限公司 |
识别tau的抗体
|
US11655307B2
(en)
|
2017-05-30 |
2023-05-23 |
The Board Of Regents Of The University Of Oklahoma |
Anti-doublecortin-like kinase 1 antibodies and methods of use
|
WO2019018744A1
(en)
|
2017-07-21 |
2019-01-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
IMMUNOGENIC COMPOSITIONS OF NEISSERIA MENINGITIDIS
|
JP7433224B2
(ja)
|
2017-11-02 |
2024-02-19 |
バイエル・アクチエンゲゼルシヤフト |
Alk-1およびbmpr-2に結合する二重特異性抗体
|
KR20210094609A
(ko)
|
2018-11-28 |
2021-07-29 |
포티 세븐, 인코포레이티드 |
절제 레짐에 대해 저항성인 유전적으로 변형된 hspc
|
TW202045206A
(zh)
|
2019-02-27 |
2020-12-16 |
美商健生生物科技公司 |
抗體調配物
|
CA3131531A1
(en)
|
2019-03-03 |
2020-09-10 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
AU2020364071A1
(en)
|
2019-10-10 |
2022-05-26 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
EP4087652A1
(en)
|
2020-01-08 |
2022-11-16 |
Regeneron Pharmaceuticals, Inc. |
Treatment of fibrodysplasia ossificans progressiva
|
WO2021211924A1
(en)
|
2020-04-16 |
2021-10-21 |
Janssen Biotech, Inc. |
Treatment of atopic dermatitis
|
CN115698068A
(zh)
|
2020-06-02 |
2023-02-03 |
艾库斯生物科学有限公司 |
抗tigit抗体
|
CA3183994A1
(en)
|
2020-06-24 |
2021-12-30 |
Philip James Dolan Iii |
Antibodies recognizing sortilin
|
WO2022157094A2
(en)
|
2021-01-22 |
2022-07-28 |
Bayer Aktiengesellschaft |
Lrrc15 antibodies and conjugates thereof
|
WO2022265912A1
(en)
|
2021-06-16 |
2022-12-22 |
Gundersen Lutheran Medical Foundation, Inc. |
Antibodies targeting an amphiregulin-derived cell surface neo-epitope
|